Podcast
Questions and Answers
What percentage of patients on immunosuppression + RASi reached clinical remission at trial endpoint?
What percentage of patients on immunosuppression + RASi reached clinical remission at trial endpoint?
- 17% (correct)
- 22%
- 5%
- 28%
How many patients taking immunosuppression had an eGFR decrease of ≥15 mL/min/1.73 m2 at trial endpoint?
How many patients taking immunosuppression had an eGFR decrease of ≥15 mL/min/1.73 m2 at trial endpoint?
- 22 (correct)
- 80
- 82
- 21
What adverse events were predominantly associated with immunosuppression?
What adverse events were predominantly associated with immunosuppression?
- Gastrointestinal and respiratory tract infections (correct)
- Musculoskeletal and urinary tract infections
- Skin and eye infections
- Cardiovascular and neurological events
What was the primary renal outcome percentage for patients taking methylprednisolone at trial endpoint?
What was the primary renal outcome percentage for patients taking methylprednisolone at trial endpoint?
What risk was associated with methylprednisolone compared to placebo?
What risk was associated with methylprednisolone compared to placebo?
How many patients on methylprednisolone developed a severe infection requiring hospitalization despite antibiotic prophylaxis within the first 12 weeks of therapy?
How many patients on methylprednisolone developed a severe infection requiring hospitalization despite antibiotic prophylaxis within the first 12 weeks of therapy?
What was the predominant ethnicity of the patient population in the testing for methylprednisolone?
What was the predominant ethnicity of the patient population in the testing for methylprednisolone?
Was proteinuria reduction still apparent in participants 36 months after randomization?
Was proteinuria reduction still apparent in participants 36 months after randomization?
Did many participants continue to gain kidney function over time?
Did many participants continue to gain kidney function over time?
